Ryvu Therapeutics Reports 2023 Half-Year Financial Results and Provides Corporate Update
The total operating revenues amounted to $7.9M and increased by 131% compared to H1 2022.Updated clinical and preclinical data on...
Year: 2023
Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease
Roche Venture Fund joins existing major investors Epidarex Capital, Sofinnova Partners and BioGeneration VenturesSeptember 13, 2023: Glasgow, Scotland – Mironid,...
Novo Nordisk conducts a two-for-one stock split
Bagsværd, Denmark, 13 September 2023 – As communicated on 10 August 2023 in connection with the release of Novo Nordisk's...
DalCor Pharmaceuticals announces Dal-GenE-2 confirmatory trial and closing of Series D financing round
MONTREAL, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DalCor Pharmaceuticals today announced the closing of the company’s Series D financing round...
Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
SAN DIEGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the...
Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023
Company to share updated results from ongoing Phase 1/2 trial of OCU400 for the treatment of Retinitis Pigmentosa and Leber...
Appeal launched to support Libya Floods Appeal
OTTAWA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the Libya Floods Appeal to help provide...
InnovAge Announces Financial Results For the Fourth Quarter and Fiscal Year Ended June 30, 2023
DENVER, Sept. 12, 2023 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq: INNV), an industry leader in...
Dyadic to Present at BioProcess International
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology...
Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference
Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 12, 2023, 10:30pm CET / 4:30pm...
Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder
Live broadcast of webinar on Tuesday, September 19 beginning at 11:30 am ETVANCOUVER, British Columbia, Sept. 12, 2023 (GLOBE NEWSWIRE)...
Advanced Health Intelligence Ltd Selected as Finalist for Singapore Ministry of Health Project
HighlightsSingapore's Centre for Healthcare Innovation and Temasek Foundation has selected AHI as a finalist for Singapore's Healthcare InnoMatch program. AHI...
Therma Bright Adds Hero LifeCare as Northeast Venowave Distribution Partner
Toronto, Ontario--(Newsfile Corp. - September 13, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer...
LanguageLine Solutions Integrates With VidaTalk, Pioneering Seamless Language Access for Healthcare Patients and Providers
ANN ARBOR, MI / ACCESSWIRE / September 13, 2023 / LanguageLine Solutions, the world leader in language access and interpretation...
Poolbeg Pharma PLC Announces Interim Results for the Six Months to 30 June 2023
Significant progress made and well positioned for future growthLONDON, UK / ACCESSWIRE / September 13, 2023 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF),...
IRLAB to present at Pareto Securities’ Healthcare Conference in Stockholm on September 14, 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / September 13, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 13, 2023 - IRLAB Therapeutics...
Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 13, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar") today announced the pricing of...
Lucy Scientific Discovery Expands its Reach in the Global Wellness Market with BlueSky Wellness Acquisition
VANCOUVER, BC / ACCESSWIRE / September 12, 2023 / Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a publicly traded company focused on...
AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
New US Prescription Drugs Cost Now More Than $200K on Average
Ongoing rise in customers ordering Rx medication from Pharmacies like Canada PharmacyVICTORIA, BC / ACCESSWIRE / September 12, 2023 /...